CFAP206

Across TCGA pan-cancer cohorts, CFAP206 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated CFAP206 data layer compared with 8 for mutation status.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher CFAP206 RNA is associated with better overall survival. In most high-consensus cancer types, elevated CFAP206 expression acts as an unfavorable survival marker, although some lineages such as OV and HNSC show a favorable association.

OV, CHOL, and HNSC are the cancer types where CFAP206 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	III,IV	0.765	0.627	.012	38	view →
CHOL	DFS	Median	II,III,IV	0.115	0.630	<.001	36	view →
HNSC	DFS	Median	IV	0.670	0.503	.003	35	view →
LGG	DFS	Quartile	All	0.728	0.881	<.001	33	view →
READ	DFS	Tertile	IV	0.179	0.671	<.001	15	view →
BLCA	OS	Median	IV	0.223	0.557	.010	12	view →
SCLC	DFS	Median	IV	0.137	0.559	.008	12	view →
THYM	DFS	Tertile	III,IV	1.000	0.417	.033	12	view →
UCEC	DFS	Quartile	IV	0.348	0.719	.035	12	view →
LUAD	OS	Median	II,III,IV	0.187	0.333	.022	12	view →
MESO	DFS	Quartile	All	0.732	0.277	.026	9	view →
SARC	OS	Median	All	0.884	0.770	.004	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

CFAP206–OV (OS)

Open the OV breakdown →